Get the latest news on current and past projects
A pioneering new mobile testing clinic will allow Leeds residents to undergo screening for two little-known conditions. SRUK is offering people the chance to take a quick non-invasive test for Raynaud's and underlying conditions, including scleroderma.
A pioneering new mobile testing clinic will be arriving in Leeds on Monday 26 June, offering local residents the opportunity to undertake a quick, non-invasive test for Raynaud's and underlying conditions linked to Raynaud's, such as the auto-immune condition scleroderma.
The pilot clinic, the first of its kind in the country, is designed to raise awareness of these two little-known conditions and facilitate further research into diagnosis and treatment that could benefit up to 10 million people in the UK. Whilst many may never have heard of the conditions, approximately 75,150 people in Leeds (1 in 10) will have Raynaud's, a disease that affects blood supply to the body's extremities.
Only a small number of patients with Raynaud's go on to develop scleroderma, a more serious connective tissue disorder which can cause disability and be life-threatening, however it is important to pick this up early so that any complications can be properly treated.
New research from Scleroderma & Raynaud's UK (SRUK) has revealed that people with scleroderma in the UK are waiting up to two years and visiting their GP an average of five times before receiving a diagnosis. Over a fifth (22%) made more than 10 visits to a health professional before a diagnosis was given.
The Leeds clinic is open to everyone, so if you (or someone you know) are displaying any of the following symptoms, which could be a sign of Raynaud's, then please come along to the testing facility:
Visitors to the clinic will be asked to place their finger under a strong microscope which shows the blood vessels under the skin. Clinicians will look at the shape and size of these capillaries to determine if they have Raynaud's and whether they are at risk of developing scleroderma.
Dr. Francesco Del Galdo, Head of Scleroderma Programme says: “7% of the UK population, 3.5 million people, will be affected by a rare disease like scleroderma at some point in their lives, yet only a tiny proportion of health funding goes on research, diagnosis and treatment of these conditions*. This pilot testing programme in Leeds is critical in helping to raise awareness of the need for greater investment in to research for Raynaud's and scleroderma, and we're hoping the data we gather could help us develop better diagnostic tests and treatments, saving time and money."
World Scleroderma Day takes place on Thursday 29th June, and will see organisations from around the world uniting to increase awareness of this rare autoimmune condition.
* Just £220,000 of health funding was spent on research into scleroderma in 2015/16, 0.02% of total spending on medical research that year.